Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Grem

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|November 1, 1991
Cardiac complications observed in elderly patients following 2'-deoxycoformycin therapyJ L Grem, S A King, H G Chun, et al.
Investigational New Drugs|August 1, 1991
Clinical use of thymidine as a rescue agent from methotrexate toxicityJ L Grem, S A King, J M Sorensen, et al.
Investigational New Drugs|May 1, 1990
Hypersensitivity reactions to trimetrexateJ L Grem, S A King, M E Costanza, et al.
Journal of the National Cancer Institute|October 19, 1988
Correlates of severe or life-threatening toxic effects from trimetrexateJ L Grem, S S Ellenberg, S A King, et al.
Journal of the National Cancer Institute|July 6, 1988
The role of methotrexate in osteosarcomaJ L Grem, S A King, R E Wittes, et al.
Cancer Treatment Reports|November 1, 1987
Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinomaJ L Grem, D D Shoemaker, N J Petrelli, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Dose-dependent inhibition of aspartate carbamoyltransferase in peripheral blood mononuclear cells in patients receiving N-(phosphonacetyl)-L-aspartateJ L Grem, N McAtee, J C Drake, et al.
Leukemia Research|January 1, 1991
Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia modelJ L Grem, J Plowman, L Rubinstein, et al.
Biochemical Pharmacology|July 29, 1999
Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cellsJ L Grem, D Nguyen, B P Monahan, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogsD M Voeller, J L Grem, Y Pommier, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|November 1, 1991
Cardiac complications observed in elderly patients following 2'-deoxycoformycin therapyJ L Grem, S A King, H G Chun, et al.
Investigational New Drugs|August 1, 1991
Clinical use of thymidine as a rescue agent from methotrexate toxicityJ L Grem, S A King, J M Sorensen, et al.
Investigational New Drugs|May 1, 1990
Hypersensitivity reactions to trimetrexateJ L Grem, S A King, M E Costanza, et al.
Journal of the National Cancer Institute|October 19, 1988
Correlates of severe or life-threatening toxic effects from trimetrexateJ L Grem, S S Ellenberg, S A King, et al.
Journal of the National Cancer Institute|July 6, 1988
The role of methotrexate in osteosarcomaJ L Grem, S A King, R E Wittes, et al.
Cancer Treatment Reports|November 1, 1987
Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinomaJ L Grem, D D Shoemaker, N J Petrelli, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Dose-dependent inhibition of aspartate carbamoyltransferase in peripheral blood mononuclear cells in patients receiving N-(phosphonacetyl)-L-aspartateJ L Grem, N McAtee, J C Drake, et al.
Leukemia Research|January 1, 1991
Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia modelJ L Grem, J Plowman, L Rubinstein, et al.
Biochemical Pharmacology|July 29, 1999
Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cellsJ L Grem, D Nguyen, B P Monahan, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogsD M Voeller, J L Grem, Y Pommier, et al.
Pageof 12